TY - JOUR
T1 - Regulation of axon degeneration after injury and in development by the endogenous calpain inhibitor calpastatin
AU - Yang, Jing
AU - Weimer, Robby M.
AU - Kallop, Dara
AU - Olsen, Olav
AU - Wu, Zhuhao
AU - Renier, Nicolas
AU - Uryu, Kunihiro
AU - Tessier-Lavigne, Marc
N1 - Funding Information:
We thank the members of the Tessier-Lavigne lab for discussion and suggestions. We are grateful to the Bio-Imaging Resource Center of the Rockefeller University for confocal microscopy. J. Y., O.O., and M.T.-L. were, and R.W. and D.K. are, employees of Genentech, a wholly owned subsidiary of Roche. This work was supported by Genentech and the Rockefeller University. The research by J.Y. was supported in part by a Bristol-Myers Squibb Postdoctoral Fellowship in Basic Neurosciences at the Rockefeller University.
PY - 2013/12/4
Y1 - 2013/12/4
N2 - Axon degeneration is widespread both in neurodegenerative disease and in normal neural development, but the molecular pathways regulating these degenerative processes and the extent to which they are distinct or overlapping remain incompletely understood. We report that calpastatin, an inhibitor of calcium-activated proteases of the calpain family, functions as a key endogenous regulator of axon degeneration. Calpastatin depletion was observed in degenerating axons after physical injury, and maintaining calpastatin inhibited degeneration of transected axons invitro and in the optic nerve invivo. Calpastatin depletion also occurred in a caspase-dependent manner in trophic factor-deprived sensory axons and was required for this invitro model of developmental degeneration. Invivo, calpastatin regulated the normal pruning of retinal ganglion cell axons in their target field. These findings identify calpastatin as a key checkpoint for axonal survival after injury and during development, and demonstrate downstream convergence of these distinct pathways of axon degeneration.
AB - Axon degeneration is widespread both in neurodegenerative disease and in normal neural development, but the molecular pathways regulating these degenerative processes and the extent to which they are distinct or overlapping remain incompletely understood. We report that calpastatin, an inhibitor of calcium-activated proteases of the calpain family, functions as a key endogenous regulator of axon degeneration. Calpastatin depletion was observed in degenerating axons after physical injury, and maintaining calpastatin inhibited degeneration of transected axons invitro and in the optic nerve invivo. Calpastatin depletion also occurred in a caspase-dependent manner in trophic factor-deprived sensory axons and was required for this invitro model of developmental degeneration. Invivo, calpastatin regulated the normal pruning of retinal ganglion cell axons in their target field. These findings identify calpastatin as a key checkpoint for axonal survival after injury and during development, and demonstrate downstream convergence of these distinct pathways of axon degeneration.
UR - http://www.scopus.com/inward/record.url?scp=84888881065&partnerID=8YFLogxK
U2 - 10.1016/j.neuron.2013.08.034
DO - 10.1016/j.neuron.2013.08.034
M3 - Article
C2 - 24210906
AN - SCOPUS:84888881065
SN - 0896-6273
VL - 80
SP - 1175
EP - 1189
JO - Neuron
JF - Neuron
IS - 5
ER -